Last reviewed · How we verify
NCT04014127: CRIB-FLOW
Coronary Microvascular Dysfunction in Chronic Kidney Disease
trial testing Coronary flow reserve assessment in Kidney Disease, Chronic in 100 participants. Status unknown.
31 August 2020
Quick facts
| Lead sponsor | University Hospital Birmingham NHS Foundation Trust |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 7 May 2019 |
| Primary completion | 31 August 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Coronary flow reserve assessment
- Sphygmocor
- Electrocardiogram
- Blood test — full drug profile →
- Urinary albumin/creatinine ratio
Conditions studied
- Kidney Disease, Chronic — all drugs for Kidney Disease, Chronic →
- Myocardial Dysfunction — all drugs for Myocardial Dysfunction →
Sponsor
University Hospital Birmingham NHS Foundation Trust
Who can join
18 and older, any sex, with Kidney Disease, Chronic or Myocardial Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an observational study assessing coronary microvascular function in healthy controls with normal kidney function, living kidney donors, pre-dialysis patients with chronic kidney disease stage 5 and patients on peritoneal dialysis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Coronary flow velocity reserve and inflammatory markers in living kidney donors.
Radhakrishnan A, Price AM, Pickup LC, Law JP, et al · · 2020 · cited 7× · PMID 32805328 · DOI 10.1016/j.ijcard.2020.08.013
Verify or expand the search:
- PubMed search for NCT04014127
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Disease, Chronic
Currently open trials in the same condition.
- NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
- NCT06343727 — A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) · NA · recruiting
- NCT06701825 — Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus · Phase 4 · recruiting
- NCT06830473 — KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection · recruiting
- NCT06863194 — Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial · Phase 1, PHASE2 · recruiting
Other University Hospital Birmingham NHS Foundation Trust trials
Trials by the same sponsor.
- NCT04916704 — Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis · active not recruiting
- NCT05376228 — A Systems Biology Approach for Identification of Host and Microbial Mechanisms and Druggable Targets for the Treatment o · unknown
- NCT04727268 — Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa · unknown
- NCT05405907 — Evaluation of the Haemostatic Agent Purabond in ENT TORS · completed
- NCT04902352 — The DISSECT Study: Effect of Peri-aDventItial SMA diSsECtion on Margin sTatus During Pancreaticoduodenectomy for Resecta · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04014127 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Birmingham NHS Foundation Trust
- Last refreshed: 10 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04014127.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing